Related Experiment Videos
[Treatment strategy in pleural mesothelioma]
J Schirren1, T Muley, P Schneider
1Chirurgische Abteilung, Thoraxklinik, Heidelberg.
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress
|February 5, 1999
Summary
Asbestos exposure causes malignant pleural mesothelioma. Surgical options include radical pleuropneumonectomy with pericardium and diaphragm resection (P3D) or palliative decortication, with complete resection offering the best prognosis.
Area of Science:
- Oncology
- Thoracic Surgery
- Environmental Medicine
Context:
- Diffuse malignant pleural mesothelioma is a rare and aggressive cancer.
- Asbestos exposure is the primary etiological factor.
- Current treatment strategies focus on surgical intervention and symptom management.
Purpose:
- To review the surgical treatment options for diffuse malignant pleural mesothelioma.
- To evaluate the prognostic factors influencing patient outcomes.
- To discuss the role of multimodal therapy and palliative care.
Summary:
- Surgical options include radical pleuropneumonectomy with pericardium and diaphragm resection (P3D) or palliative pleurectomy/decortication.
- P3D is most effective in early-stage epithelial mesothelioma; complete resection yields the best prognosis.
- Prognosis after radical resection is similar to palliative decortication; multimodal therapy shows promise for improved survival.
Impact:
- Highlights the importance of complete tumor resection for optimal outcomes.
- Underscores the palliative role of surgery in advanced disease.
- Suggests a need for further research into multimodal treatment strategies for mesothelioma.